HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Print Friendly, PDF & Email

NCT/Study#

NA /

DGF60021-600201

Dose Escalation In Patients With Advanced Solid Tumors, And Expansion In Selected Indications

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: